Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
stock ticker
|
| gptkbp:businessModel |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Lloyd_M._Segal
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
precision oncology
|
| gptkbp:foundedYear |
2016
|
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
RPTX
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:ISIN |
CA7602731021
|
| gptkbp:listedOn |
gptkb:NASDAQ
|
| gptkbp:refersTo |
gptkb:Repare_Therapeutics
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:symbol |
Repare Therapeutics Inc.
|
| gptkbp:bfsParent |
gptkb:Repare_Therapeutics
|
| gptkbp:bfsLayer |
7
|